Cranberry as promising natural source of potential anticancer agents: Current evidence and future perspectives

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 6, 2012, Pages 619-630

  Katsargyris, Athanasios ^a   Tampaki, Ekaterini Christina ^a   Giaginis, Constantinos ^b   Theocharis, Stamatios ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF THE AEGEAN   (Greece)

Author keywords

Cancer; Cranberry; Inflammation; Oxidative stress; Quercetin; Ursolic acid

Indexed keywords

ANTHOCYANIN; ANTINEOPLASTIC AGENT; CATECHIN; CISPLATIN; COUMARIC ACID; CRANBERRY EXTRACT; DOXORUBICIN; EPICATECHIN; FLAVAN 3 OL DERIVATIVE; FLAVONOID; FLAVONOL DERIVATIVE; HYDROXYBENZOIC ACID; MYRICETIN; NONSTEROID ANTIINFLAMMATORY AGENT; PACLITAXEL; PEONIDIN DERIVATIVE; PHENOL DERIVATIVE; PROANTHOCYANIDIN DERIVATIVE; QUERCETIN; RIBAVIRIN; TIAZOFURIN; TRITERPENOID; UNCLASSIFIED DRUG; URSOLIC ACID;

ANGIOGENESIS; ANTIANGIOGENIC ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; BLADDER CANCER; BREAST CANCER; CANCER INHIBITION; CANCER RISK; COLON ADENOCARCINOMA; COLON CANCER; CRANBERRY; DRUG POTENTIATION; ESOPHAGUS CANCER; G1 PHASE CELL CYCLE CHECKPOINT; HELICOBACTER INFECTION; HUMAN; LIVER CANCER; LUNG CANCER; MELANOMA; MOUTH SQUAMOUS CELL CARCINOMA; NONHUMAN; OXIDATIVE STRESS; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK REDUCTION; STOMACH CANCER; URINARY TRACT INFECTION;

EID: 84861697049     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012800617669     Document Type: Review

References (140)

1. Willett, W.C. Diet, nutrition, and avoidable cancer. Environ. Health. Perspect., 1995, 103(8), 165-170.
2. Ferguson, P.J.; Kurowska, E.; Freeman, D.J.; Chambers, A.F.; Koropatnick, D.J. A flavonoid fraction from cranberry extract inhibits proliferation of human tumor cell lines. J. Nutr., 2004, 134(6),1529-1535.
3. Sun, J.; Hai Liu, R. Cranberry phytochemical extracts induce cell cycle arrest and apoptosis in human MCF-7 breast cancer cells. Cancer. Lett., 2006, 241(1),124-134.
4. Heber D. The role of nutrition in cancer prevention and control. Oncology (Williston Park), 1992, 6, 9-14.
5. Platz, E.A.; Willett, W.C.; Colditz, G.A.; Rimm, E.B.; Spiegelman, D.; Giovannucci, E. Proportion of colon cancer risk that might be preventable in a cohort of middle-aged US men. Cancer Causes Control, 2000, 1(7),579-588.
6. Hong, W.K.; Sporn, M.B. Recent advances in chemoprevention of cancer. Science, 1997, 278(5340), 1073-1077.
7. Manu, K.A.; Kuttan, G. Ursolic acid induces apoptosis by activating p53 and caspase-3 gene expressions and suppressing NFkappaB mediated activation of bcl-2 in B16F-10 melanoma cells. Int. Immunopharmacol., 2008, 8(7), 974-981.
8. Kresty, L.A.; Howell, A.B.; Baird, M. Cranberry proanthocyanidins induce apoptosis and inhibit acid-induced proliferation of human esophageal adenocarcinoma cells. J. Agric. Food Chem., 2008, 56(3), 676-680.
9. Deziel, B.A.; Patel, K.; Neto,. C; Gottschall-Pass, K.; Hurta, R.A. Proanthocyanidins from the American Cranberry (Vaccinium macrocarpon) inhibit matrix metalloproteinase-2 and matrix metalloproteinase-9 activity in human prostate cancer cells via alterations in multiple cellular signalling pathways. J. Cell Biochem., 2010, 111(3), 742-754.
10. Singh, A.P.; Singh, R.K.; Kim, K.K.; Satyan, K.S.; Nussbaum, R.; Torres, M.; Brard, L.; Vorsa, N. Cranberry proanthocyanidins are cytotoxic to human cancer cells and sensitize platinum-resistant ovarian cancer cells to paraplatin. Phytother Res, 2009, 23(8), 1066-1074.
11. Jo, M.; Nishikawa, T.; Nakajima, T.; Okada, Y.; Yamaguchi, K.; Mitsuyoshi, H.; Yasui, K.; Minami, M.; Iwai, M.; Kagawa, K.; Itoh, Y.; Yoshikawa, T. Oxidative stress is closely associated with tumor angiogenesis of hepatocellular carcinoma. J. Gastroenterol., 2011, 46(6), 809-821.
12. Acquaviva, R.; Iauk, L.; Sorrenti, V.; Lanteri, R.; Santangelo, R.; Licata, A.; Vanella, A.; Malaguarnera, M.; Ragusa, S.; Di Giacomo, C. Oxidative profile in patients with colon cancer: effects of Ruta chalepensis L. Eur Rev Med Pharmacol Sci, 2011, 15(2), 181-191.
13. Damgaardm, R.B.; Gyrd-Hansen, M. Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity. Discov Med, 2011, 11(58), 221-231.
14. Omabe, M; Ezeani, M. Infection, inflammation and prostate carcinogenesis. Infect. Genet. Evol., 2011, 11(6), 1195-1198.
15. Cote, J.; Caillet, S.; Doyon, G.; Sylvain, J.F.; Lacroix, M. Analyzing cranberry bioactive compounds. Crit. Rev. Food Sci. Nutr., 2010, 50(9), 872-888.
16. Macheix, J.J.; Fleuriet, A.; Billot A. Fruit Phenolics. CRC Press,1990.
17. Neto C.C. Cranberry and its phytochemicals: A review of in vitro anticancer studies. J. Nutr., 2007, 137, 186-193.
18. Wu, X.; Beecher, G. R.; Holden, J. M.; Haytowitz, D. B.; Gebhardt, S. E.; Prior, RL. Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem., 2006, 54, 4069-4075.
19. Brown, P.N.; Shipley, P.R. Determination of anthocyanins in cranberry fruit and cranberry fruit products by high-performance liquid chromatography with ultraviolet detection: single-laboratory validation. J. A.O.A.C., 2011, 94(2), 459-466.
20. Pappas, E.; Schaich, K.M. Phytochemicals of cranberries and cranberry products: characterization, potential health effects, and processing stability. Crit. Rev. Food Sci. Nutr., 2009, 49(9), 741-781.
21. Lin, L.Z.; Harnly, J.M. A screening method for the identification of glycosylated flavonoids and other phenolic compounds using a standard analytical approach for all materials. J. Agric. Food Chem., 2007, 55(4), 1084-1096.
22. USDA Database for the flavonoid content of selected foods. 2007, Release 2.1. http://www.nal.usda.gov/fnic/foodcomp/Data/Flav/Flav02-1.pdf
23. USDA Database for the proanthocyanidin content of selected foods. 2004. http://www.nal.usda.gov/fnic/foodcomp/Data/PA/PA. html
24. Howell, A.B.; Reed, J.D.; Krueger, C.G.; Winterbottom, R.; Cunningham, D.G.; Leahy, M. A-type cranberry proanthocyanidins and uropathogenic bacterial anti-adhesion activity. Phytochem., 2005, 66(18), 2281-2291.
25. Kondo M. Phytochemical studies of extracts from cranberry (Vaccinium macrocarpon) with anticancer, antifungal and cardioprotective properties. Ms Thesis, University of Massachusetts, Dartmouth 2006.
26. He, X.; Liu, R.H. Cranberry phytochemicals: isolation, structure elucidation, and their antiproliferative and antioxidant activities. J. Agric. Food Chem., 2006, 54(19), 7069-7074.
27. Raghavan, S; Richards, MP. Comparison of solvent and microwave extracts of cranberry press cake on the inhibition of lipid oxidation in mechanically separated turkey. Food Chem., 2007, 102(3), 818-826.
28. Duke J.A. Handbook of phytochemical constituents of GRAS herbs and other economic plants. CRC Press. 1992.
29. Kaponen, J.M.; Happonen, A.M.; Mattila, P.H.; Törrönen, AR. Contents of anthocyanins and ellagitannins in selected foods consumed in Finland. J. Agric. Food Chem., 2007, 55(4), 1612-1619.
30. Rimando, A.M.; Kalt, W.; Magee, J.B.; Dewey, J.; Ballington, J.R. Resveratrol, pterostilbene, and piceatannol in Vaccinium berries. J. Agric. Food Chem., 2004, 52(15), 4713-4719.
31. Prasain, J.K.; Jones, K.; Moore, R.; Barnes, S.; Leahy, M.; Roderick, R., et al. Effect of cranberry juice concentrate on chemically-induced urinary bladder cancers. Oncol. Rep., 2008, 19(6), 1565-1570.
32. Kresty, L.A.; Howell, A.B.; Baird, M. Cranberry Proanthocyanidins Mediate Growth Arrest of Lung Cancer Cells through Modulation of Gene Expression and Rapid Induction of Apoptosis. Molecules, 2011, 116(3), 2375-2390.
33. Neto, C.C.; Amoroso, J.W.; Liberty, A.M. Anticancer activities of cranberry phytochemicals: an update. Mol. Nutr. Food Res., 2008, 52, 18-27.
34. Vinson, J.A.; Su, X.; Zubik, L.; Bose, P. Phenol antioxidant quantity and quality in foods: fruits. J. Agric. Food Chem., 2001, 49(11), 5315-5321.
35. Chu, Y.F.; Sun, J.; Wu, X.; Liu, R.H. Antioxidant and antiproliferative activities of common vegetables. J. Agric. Food Chem., 2002, 50(23), 6910-6916.
36. Yan, X.; Murphy, B.T.; Hammond, G.B.; Vinson, J.A.; Neto, C.C. Antioxidant activities and antitumor screening of extracts from cranberry fruit (Vaccinium macrocarpon). J. Agric. Food Chem., 2002, 50(21), 5844-5849.
37. Youdim, K.A.; McDonald, J.; Kalt, W.; Joseph, J.A. Potential role of dietary flavonoids in reducing microvascular endothelium vulnerability to oxidative and inflammatory insults. J. Nutr. Biochem., 2002, 13(5), 282-288.
38. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem. J., 2007, 401(1), 1-11.
39. Kandil, FE; Smith, MA; Rogers, RB; Pepin, MF; Song, LL; Pezzuto, JM; Seigler, DS. Composition of a chemopreventive proanthocyanidin-rich fraction from cranberry fruits responsible for the inhibition of 12-O-tetradecanoyl phorbol-13-acetate (TPA)-induced ornithine decarboxylase (ODC) activity. J. Agric. Food Chem., 2002, 50(5), 1063-1069.
40. Auvinen M. Cell transformation, invasion, and angiogenesis: a regulatory role for ornithine decarboxylase and polyamines? J. Natl. Cancer Inst., 1997, 89(8), 533-537.
41. Seeram, N.P.; Adams, L.S.; Hardy, M.L.; Heber, D. Total cranberry extract versus its phytochemical constituents: antiproliferative and synergistic effects against human tumor cell lines. J. Agric. Food Chem., 2004, 52(9), 2512-2517.
42. Choi, J.A.; Kim, J.Y.; Lee, J.Y.; Kang, C.M.; Kwon, H.J.; Yoo, Y.D.; Kim, T.W.; Lee, Y.S.; Lee, S.J. Induction of cell cycle arrest and apoptosis in human breast cancer cells by quercetin. Int. J. Oncol., 2001, 19(4), 837-844.
43. Ramos, S.; Alia, M.; Bravo, L.; Goya L. Comparative effects of food-derived polyphenols on the viability and apoptosis of a human hepatoma cell line (HepG2). J. Agric. Food Chem., 2005, 53(4), 1271-1280.
44. Richter, M.; Ebermann, R.; Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr. Cancer, 1999, 34(1), 88-99.
45. Lee, L.T.; Huang, Y.T.; Hwang, J.J.; Lee, P.P.; Ke, F.C.; Nair, M.P.; Kanadaswam, C.; Lee, M.T. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells. Anticancer Res., 2002, 22(3), 1615-1627.
46. Ranelletti, F.O.; Maggiano, N.; Serra, F.G.; Ricci, R.; Larocca, L.M.; Lanza, P.; Scambia, G.; Fattorossi, A.; Capelli, A.; Piantelli, M. Quercetin inhibits p21-RAS expression in human colon cancer cell lines and in primary colorectal tumors. Int. J. Cancer, 2000, 85(3), 438-445.
47. Bottone, F.G., Jr; Martinez, J.M., Alston-Mills, B.; Eling, T.E. Gene modulation by Cox-1 and Cox-2 specific inhibitors in human colorectal carcinoma cancer cells. Carcinogenesis, 2004, 25(3), 349-357.
48. Fournier, D.B.; Gordon, G.B. COX-2 and colon cancer: potential targets for chemoprevention. J. Cell. Biochem. Suppl, 2000, 34, 97-102.
49. Lanas, A.; Ferrandez, A. NSAIDs and the colon. Curr. Opin. Gastroenterol., 2009, 25(1), 44-9.
50. Sheng H., Shao J., Kirkland S.C., Isakson P., Coffey R.J., Morrow J., Beauchamp R.D., DuBois R.N. Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. Clin. Invest. 1997, 99(9), 2254-2259.
51. Seeram, N.P.; Momin, R.A.; Nair, M.G.; Bourquin, L.D. Cyclooxygenase inhibitory and antioxidant cyanidin glycosides in cherries and berries. Phytomedicine, 2001, 8(5), 362-369.
52. Subbaramaiah, K.; Michaluart, P.; Sporn, M.B.; Dannenberg, A.J. Ursolic acid inhibits cyclooxygenase-2 transcription in human mammary epithelial cells. Cancer Res., 2000, 60(9), 2399-2404.
53. O'Leary, K.A.; de Pascual-Tereasa, S.; Needs, P.W.; Bao, Y.P.; O'Brien, N.M.; Williamson, G. Effect of flavonoids and vitamin E on cyclooxygenase-2 (COX-2) transcription. Mutat. Res., 2004, 551(12), 245-254.
54. Kim, H.; Kong, H.; Choi, B.; Yang, Y.; Kim, Y.; Lim, M.J.; Neckers, L.; Jung, Y. Metabolic and pharmacological properties of rutin, a dietary quercetin glycoside, for treatment of inflammatory bowel disease. Pharm. Res., 2005, 22(9), 1499-1509.
55. Shishodia, S.; Majumdar, S.; Banerjee, S.; Aggarwal, B.B. Ursolic acid inhibits nuclear factor-kappaB activation induced by carcinogenic agents through suppression of IkappaBalpha kinase and p65 phosphorylation: correlation with down-regulation of cyclooxygenase 2, matrix metalloproteinase 9, and cyclin D1. Cancer Res., 2003, 63(15), 4375-4383.
56. Garcia-Mediavilla, V.; Crespo, I.; Collado, P.S.; Esteller, A.; Sanchez-Campos, S.; Tunon, M.J.; González-Gallego, J. The antiinflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells. Eur. J. Pharmacol., 2007, 557(2-3), 221-229.
57. Cha, H.J.; Bae, S.K.; Lee, H.Y.; Lee, O.H.; Sato, H.; Seiki, M.; Park, B.C.; Kim, K.W. Anti-invasive activity of ursolic acid correlates with the reduced expression of matrix metalloproteinase-9 (MMP-9) in HT1080 human fibrosarcoma cells. Cancer Res., 1996, 56(10), 2281-2284.
58. Neto C.C. Cranberry and blueberry: evidence for protective effects against cancer and vascular diseases. Mol. Nutr. Food Res., 2007, 51(6), 652-664.
59. Roy, S.; Khanna, S.; Alessio, H.M.; Vider, J.; Bagchi, D.; Bagchi, M.; Sen, C.K. Anti-angiogenic property of edible berries. Free Radic. Res., 2002, 36(9), 1023-1031.
60. Bagchi, D.; Sen, C.K.; Bagchi, M.; Atalay, M. Anti-angiogenic, antioxidant, and anti-carcinogenic properties of a novel anthocyanin-rich berry extract formula. Biochemistry (Mosc), 2004, 69(1), 75-80.
61. Oh, S.J.; Kim, O.; Lee, J.S.; Kim, J.A.; Kim, M.R.; Choi, H.S.; Shim, J.H.; Kang, K.W.; Kim, Y.C. Inhibition of angiogenesis by quercetin in tamoxifen-resistant breast cancer cells. Food Chem. Toxicol., 2010, 48(11), 3227-3234.
62. Larocca, LM; Giustacchini, M; Maggiano, N; Ranelletti, FO; Piantelli, M; Alcini, E; Capelli, A. Growth-inhibitory effect of quercetin and presence of type II estrogen binding sites in primary human transitional cell carcinomas. J. Urol., 1994, 152(3), 1029-1033.
63. Grubbs, C.J.; Lubet, R.A.; Koki, A.T.; Leahy, K.M.; Masferrer, J.L.; Steele, V.E.; Kelloff, G. J; Hill, D.L.; Seibert, K. Celecoxib inhibits N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancers in male B6D2F1 mice and female Fischer-344 rats. Cancer Res., 2000, 60(20), 5599-5602.
64. Rao, K.V.; Detrisac, C.J.; Steele, V.E.; Hawk, E.T.; Kelloff, G.J.; McCormick, D.L. Differential activity of aspirin, ketoprofen and sulindac as cancer chemopreventive agents in the mouse urinary bladder. Carcinogenesis, 1996, 17(7), 1435-1438.
65. Moon, R.C.; Kelloff, G.J.; Detrisac, C.J.; Steele, V.E.; Thomas, C.F.; Sigman, C.C. Chemoprevention of OH-BBN-induced bladder cancer in mice by piroxicam. Carcinogenesis, 1993, 14(7), 1487-1489.
66. Nakatsugi, S.; Ohta, T.; Kawamori, T.; Mutoh, M.; Tanigawa, T.; Watanabe, K.; Sugie, S.; Sugimura, T.; Wakabayashi, K. Chemoprevention by nimesulide, a selective cyclooxygenase-2 inhibitor, of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-induced mammary gland carcinogenesis in rats. Jpn J. Cancer Res., 2000, 91(9), 886-892.
67. Sun, J.; Chu, Y.F.; Wu, X.; Liu, R.H. Antioxidant and antiproliferative activities of common fruits. J. Agric. Food Chem., 2002, 50(25), 7449-7454.
68. Garcia Mediero, J.M.; Ferruelo Alonso, A.; Paez Borda, A.; Lujan Galan, M.; Angulo Cuesta, J.; Chiva Robles, V.; Berenguer Sánchez, A. [Effect of polyphenols from the Mediterranean diet on proliferation and mediators of in vitro invasiveness of the MB-49 murine bladder cancer cell line]. Actas Urol. Esp., 2005, 29(8), 743-749.
69. Ma, L; Feugang, JM; Konarski, P; Wang, J; Lu, J; Fu, S; Ma, B; Tian, B; Zou, C; Wang, Z. Growth inhibitory effects of quercetin on bladder cancer cell. Front. Biosci., 2006, 11, 2275-2285.
70. Chadalapaka, G.; Jutooru, I.; McAlees, A.; Stefanac, T.; Safe, S. Structure-dependent inhibition of bladder and pancreatic cancer cell growth by 2-substituted glycyrrhetinic and ursolic acid derivatives. Bioorg. Med. Chem. Lett., 2008, 18(8), 2633-2639.
71. Luo, H.; Jiang, B.H.; King, S.M.; Chen, Y.C. Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids. Nutr. Cancer, 2008, 60(6), 800-809.
72. Wang, X.; Li, L.; Wang, B.; Xiang, J. Effects of ursolic acid on the proliferation and apoptosis of human ovarian cancer cells. J. Huazhong Univ. Sci. Technolog. Med. Sci., 2009, 29(6), 761-764.
73. Li, W.; Shen, F.; Weber, G. Ribavirin and quercetin synergistically downregulate signal transduction and are cytotoxic in human ovarian carcinoma cells. Oncol. Res., 1999, 11(5), 243-247.
74. Shen, F.; Herenyiova, M.; Weber, G. Synergistic down-regulation of signal transduction and cytotoxicity by tiazofurin and quercetin in human ovarian carcinoma cells. Life Sci. 1999, 64(21), 1869-1876.
75. Vidya Priyadarsini, R.; Senthil Murugan, R.; Maitreyi, S.; Ramalingam, K.; Karunagaran, D.; Nagini, S. The flavonoid quercetin induces cell cycle arrest and mitochondria-mediated apoptosis in human cervical cancer (HeLa) cells through p53 induction and NF-kappaB inhibition. Eur. J. Pharmacol., 2010, 649(1), 84-91.
76. Zhang, W.; Zhang, F. Effects of quercetin on proliferation, apoptosis, adhesion and migration, and invasion of HeLa cells. Eur. J. Gynaecol. Oncol., 2009, 30(1), 60-64.
77. Murphy, B.T.; MacKinnon, S.L.; Yan, X.; Hammond, G.B.; Vaisberg, A.J.; Neto, C.C. Identification of triterpene hydroxycinnamates with in vitro antitumor activity from whole cranberry fruit (Vaccinium macrocarpon). J. Agric. Food Chem., 2003, 51(12), 3541-3545.
78. Yim, E.K.; Lee, M.J.; Lee, K.H.; Um, S.J.; Park, J.S. Antiproliferative and antiviral mechanisms of ursolic acid and dexamethasone in cervical carcinoma cell lines. Int. J. Gynecol. Cancer, 2006, 16(6), 2023-2031.
79. Li, Y.; Xing, D.; Chen, Q.; Chen, W.R. Enhancement of chemotherapeutic agent-induced apoptosis by inhibition of NFkappaB using ursolic acid. Int. J. Cancer, 2010, 127(2), 462-473.
80. Beslija, S.; Bonneterre, J.; Burstein, H.; Cocquyt, V.; Gnant, M.; Goodwin, P.; Heinemann, V.; Jassem, J.; Köstler, W.J.; Krainer, M.; Menard, S.; Petit, T.; Petruzelka, L.; Possinger, K.; Schmid, P.; Stadtmauer, E.; Stockler, M.; Van Belle, S.; Vogel, C.; Wilcken, N.; Wiltschke, C.; Zielinski, C.C.; Zwierzina, H. Second consensus on medical treatment of metastatic breast cancer. Ann. Oncol., 2007, 18(2), 215-225.
81. CDC, US Cancer Statistics Working Group. Top 10 Causes of Death for Women in the United States (2003). CDC Statistics, 2007.
82. Howe, G.R.; Hirohata, T.; Hislop, T.G.; Iscovich, J.M.; Yuan, J.M.; Katsouyanni, K.; Lubin, F.; Marubini, E.; Modan, B; Rohan, T. Dietary factors and risk of breast cancer: combined analysis of 12 case-control studies. J. Natl. Cancer Inst., 1990, 82(7), 561-559.
83. Wang, J.S.; Ren, T.N.; Xi, T. Ursolic acid induces apoptosis by suppressing the expression of FoxM1 in MCF-7 human breast cancer cells. Med. Oncol., 2010 Dec 30 (Epub ahead of print)
84. De Angel, R.E.; Smith, S.M.; Glickman, R.D.; Perkins, S.N.; Hursting, S.D. Antitumor effects of ursolic acid in a mouse model of postmenopausal breast cancer. Nutr. Cancer, 2010, 62(8), 1074-1086.
85. Kassi, E.; Sourlingas, T.G.; Spiliotaki, M.; Papoutsi, Z.; Pratsinis, H.; Aligiannis, N.; Moutsatsou, P. Ursolic acid triggers apoptosis and Bcl-2 downregulation in MCF-7 breast cancer cells. Cancer Invest,. 2009, 27(7), 723-733.
86. Chou, C.C.; Yang, J.S.; Lu, H.F.; Ip, S.W.; Lo, C.; Wu, C.C.; Lin, J.P.; Tang, N.Y.; Chung, J.G.; Chou, M.J.; Teng, Y.H.; Chen,. DR. Quercetin-mediated cell cycle arrest and apoptosis involving activation of a caspase cascade through the mitochondrial pathway in human breast cancer MCF-7 cells. Arch. Pharm. Res., 2010, 33(8), 1181-1191.
87. Staedler, D.; Idrizi, E.; Kenzaoui, B.H.; Juillerat-Jeanneret, L. Drug combinations with quercetin: doxorubicin plus quercetin in human breast cancer cells. Cancer Chemother. Pharmacol. 2011 Mar 13. [Epub ahead of print]
88. Singh, B.; Mense, S.M.; Bhat, N.K.; Putty, S.; Guthiel, W.A.; Remotti, F.; Bhat, H.K. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. Toxicol. Appl. Pharmacol., 2010, 247(2), 83-90.
89. Yeh, C.T.; Wu, C.H.; Yen, G.C. Ursolic acid, a naturally occurring triterpenoid, suppresses migration and invasion of human breast cancer cells by modulating c-Jun N-terminal kinase, Akt and mammalian target of rapamycin signaling. Mol. Nutr. Food Res., 2010, 54(9), 1285-1295.
90. MacLean, M.A.; Scott, B.E.; Deziel, B.A.; Nunnelley, M.C.; Liberty, A.M.; Gottschall-Pass, K.T.; Neto, C.C.; Hurta, R.A. et al. North American cranberry (Vaccinium macrocarpon) stimulates apoptotic pathways in DU145 human prostate cancer cells in vitro. Nutr. Cancer, 2011, 63(1), 109-120.
91. Ferguson, P.J.; Kurowska, E.M.; Freeman, D.J.; Chambers, A.F.; Koropatnick, J. In vivo inhibition of growth of human tumor lines by flavonoid fractions from cranberry extract. Nutr. Cancer, 2006, 56(1), 86-94.
92. Zhang, Y.; Kong, C.; Zeng, Y.; Wang, L.; Li, Z.; Wang, H.; Xu, C.; Sun, Y. Ursolic acid induces PC-3 cell apoptosis via activation of JNK and inhibition of Akt pathways in vitro. Mol. Carcinog., 2010, 49(4), 374-385.
93. Senthilkumar, K.; Arunkumar, R.; Elumalai, P.; Sharmila, G.; Gunadharini, D.N.; Banudevi, S.; Krishnamoorthy, G.; Benson, C.S.; Arunakaran, J. Quercetin inhibits invasion, migration and signalling molecules involved in cell survival and proliferation of prostate cancer cell line (PC-3). Cell. Biochem. Funct., 2011, 29(2), 87-95.
94. Tang, S.N.; Singh, C.; Nall, D.; Meeker, D.; Shankar, S.; Srivastava, R.K. The dietary bioflavonoid quercetin synergizes with epigallocathechin gallate (EGCG) to inhibit prostate cancer stem cell characteristics, invasion, migration and epithelialmesenchymal transition. J. Mol. Signal., 2010, 5, 14.
95. King, M.; Chatelain, K.; Farris, D.; Jensen, D.; Pickup, J.; Swapp, A.; O'Malley, S.; Kingsley, K. Oral squamous cell carcinoma proliferative phenotype is modulated by proanthocyanidins: a potential prevention and treatment alternative for oral cancer. BMC Complement Altern. Med., 2007, 7, 22.
96. Chatelain, K.; Phippen, S.; McCabem J.; Teeters, C.A., O'Malley S., Kingsley K. Cranberry and Grape Seed Extracts Inhibit the Proliferative Phenotype of Oral Squamous Cell Carcinomas. Evid. Based Complement Alternat. Med., 2008 Jul 23. [Epub ahead of print].
97. Kang, J.W.; Kim, J.H.; Song, K.; Kim, S.H.; Yoon, J.H.; Kim, K.S. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother. Res., 2010, S1, S77-82.
98. Yamai, H.; Sawada, N.; Yoshida, T.; Seike, J.; Takizawa, H.; Kenzaki, K.; Miyoshi, T.; Kondo, K.; Bando, Y.; Ohnishi, Y.; Tangoku, A. Triterpenes augment the inhibitory effects of anticancer drugs on growth of human esophageal carcinoma cells in vitro and suppress experimental metastasis in vivo. Int. J. Cancer, 2009, 125(4), 952-960.
99. Zhang, Q.; Zhao, X.H.; Wang, Z.J. Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis. Toxicol. In Vitro, 2009, 23(5), 797-807.
100. Zhang, Q.; Zhao, X.H.; Wang, Z.J. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem. Toxicol., 2008, 46(6), 2042-2053.
101. Cheong, E.; Ivory, K.; Doleman, J.; Parker, M.L.; Rhodes, M.; Johnson, I.T. Synthetic and naturally occurring COX-2 inhibitors suppress proliferation in a human oesophageal adenocarcinoma cell line (OE33) by inducing apoptosis and cell cycle arrest. Carcinogenesis, 2004, 25(10), 1945-1952.
102. Malfertheiner, P.; Sipponen, P.; Naumann, M.; Moayyedi, P.; Megraud, F.; Xiao, S.D.; Sugano, K.; Nyrén, O.; Lejondal, H. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am. J. Gastroenterol., 2005, 100(9), 2100-2115.
103. Zhang, L.; Ma, J.; Pan, K.; Go, V.L.; Chen, J.; You, W.C. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter., 2005, 10(2), 139-145.
104. Burger, O.; Ofek, I.; Tabak, M.; Weiss, E.I.; Sharon, N.; Neeman, I. A high molecular mass constituent of cranberry juice inhibits helicobacter pylori adhesion to human gastric mucus. FEMS Immunol. Med. Microbiol., 2000, 29(4), 295-301.
105. Boivin, D.; Blanchette, M.; Barrette, S.; Moghrabi, A.; Beliveau, R. Inhibition of cancer cell proliferation and suppression of TNFinduced activation of NFkappaB by edible berry juice. Anticancer Res., 2007, 27(2), 937-948.
106. Liu, M.; Lin, L.Q.; Song, B.B.; Wang, L.F.; Zhang, C.P.; Zhao, J.L.; Liu, J.R. Cranberry phytochemical extract inhibits SGC-7901 cell growth and human tumor xenografts in Balb/c nu/nu mice. J. Agric. Food Chem., 2009, 57(2), 762-768.
107. Granado-Serrano, A.B.; Martin, M.A.; Bravo, L.; Goya, L.; Ramos, S. Quercetin modulates NF-kappa B and AP-1/JNK pathways to induce cell death in human hepatoma cells. Nutr. Cancer, 2010, 62(3), 390-401.
108. Kim, J.Y.; Kim, E.H.; Park, S.S.; Lim, J.H.; Kwon, T.K.; Choi, K.S. Quercetin sensitizes human hepatoma cells to TRAIL-induced apoptosis via Sp1-mediated DR5 up-regulation and proteasomemediated c-FLIPS down-regulation. J. Cell. Biochem., 2008, 105(6), 1386-1398.
109. Yang, L.; Liu, X.; Lu, Z.; Yuet-Wa Chan, J.; Zhou, L.; Fung, K.P.; Wu, P.; Wu, S. Ursolic acid induces doxorubicin-resistant HepG2 cell death via the release of apoptosis-inducing factor. Cancer Lett., 2010, 298(1), 128-138.
110. Lee, H.Z.; Bau, D.T.; Kuo, C.L.; Tsai, R.Y.; Chen, Y.C.; Chang, Y.H. Clarification of the phenotypic characteristics and anti-tumor activity of Hedyotis diffusa. Am. J. Chin. Med., 2011, 39(1), 201-213.
111. Yu, Y.X.; Gu, Z.L.; Yin, J.L.; Chou, W.H.; Kwok, C.Y.; Qin, Z.H.; Liang, Z.Q. Ursolic acid induces human hepatoma cell line SMMC-7721 apoptosis via p53-dependent pathway. Chin. Med. J. (Engl), 2010, 123(14), 1915-1923.
112. Yuan, Z.P.; Chen, L.J.; Fan, L.Y.; Tang, M.H.; Yang, G.L.; Yang, H.S.; Du, X.B.; Wang, G.Q.; Yao, W.X.; Zhao, Q.M.; Ye, B.; Wang, R.; Diao, P.; Zhang, W.; Wu, H.B.; Zhao, X.; Wie, Y.Q. Liposomal quercetin efficiently suppresses growth of solid tumors in murine models. Clin. Cancer Res., 2006, 12(10), 3193-3199.
113. Lin, C.C.; Huang, C.Y.; Mong, M.C.; Chan, C.Y.; Yin, M.C. Antiangiogenic potential of three triterpenic acids in human liver cancer cells. J. Agric. Food Chem., 2011, 59(2), 755-762.
114. Wolfe, K.L.; Liu, R.H. Cellular antioxidant activity (CAA) assay for assessing antioxidants, foods, and dietary supplements. J. Agric. Food Chem., 2007, 55(22), 8896-9907.
115. Shimada, Y.; Dewa, Y.; Ichimura, R.; Suzuki, T.; Mizukami, S.; Hayashi, S.M.; Shibutani, M.; Mitsumori, K. Antioxidant enzymatically modified isoquercitrin suppresses the development of liver preneoplastic lesions in rats induced by betanaphthoflavone. Toxicology, 2010, 268(3), 213-218.
116. Nishimura, J.; Saegusa, Y.; Dewa, Y.; Jin, M.; Kawai, M.; Kemmochi, S.; Harada, T.; Hayashi, S.M.; Shibutani, M.; Mitsumori, K. Antioxidant enzymatically modified isoquercitrin or melatonin supplementation reduces oxidative stress-mediated hepatocellular tumor promotion of oxfendazole in rats. Arch. Toxicol., 2010, 84(2), 143-153.
117. Seufi, A.M.; Ibrahim, S.S.; Elmaghraby, T.K.; Hafez, E.E. Preventive effect of the flavonoid, quercetin, on hepatic cancer in rats via oxidant/antioxidant activity: molecular and histological evidences. J. Exp. Clin. Cancer Res., 2009, 28, 80.
118. Gayathri, R.; Priya, D.K.; Gunassekaran, G.R.; Sakthisekaran, D. Ursolic acid attenuates oxidative stress-mediated hepatocellular carcinoma induction by diethylnitrosamine in male Wistar rats. Asian Pac. J. Cancer Prev., 2009, 10(5), 933-938.
119. Volate, S.R.; Davenport, D.M.; Muga, S.J.; Wargovich, M.J. Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin). Carcinogenesis, 2005, 26(8), 1450-1456.
120. Moreira, L.; Castells, A. Cyclooxygenase as a Target for Colorectal Cancer Chemoprevention. Curr. Drug Targets, 2010, Dec 15. [Epub ahead of print]
121. Lai, M.Y.; Leung, H.W.; Yang, W.H.; Chen, W.H.; Lee, H.Z. Upregulation of matrix metalloproteinase family gene involvement in ursolic acid-induced human lung non-small carcinoma cell apoptosis. Anticancer Res., 2007, 27(1A), 145-153.
122. Yeh, S.L.; Yeh, C.L.; Chan, S.T.; Chuang, C.H. Plasma Rich in Quercetin Metabolites Induces G2/M Arrest by Upregulating PPAR-gamma Expression in Human A549 Lung Cancer Cells. Planta Med., 2011, 77(10), 992-998.
123. Lam, T.K.; Rotunno, M.; Lubin, J.H.; Wacholder, S.; Consonni, D.; Pesatori, A.C.; Bertazzi, P.A.; Chanock, S.J.; Burdette, L.; Goldstein, A.M.; Tucker, M.A.; Caporaso, N.E.; Subar, A.F.; Landi, M.T. Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis, 2010, 31(4), 634-642.
124. Hsu, HS; Lin, JH; Huang, WC; Hsu, TW; Su, K; Chiou, SH; Tsai, YT; Hung, SC. Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer, 2011, 117(7),1516-1528.
125. Izumi, H.; Takahashi, M.; Uramoto, H.; Nakayama, Y.; Oyama, T.; Wang, K.Y.; Sasaguri, Y.; Nishizawa, S.; Kohno, K. Monocarboxylate transporters 1 and 4 are involved in the invasion activity of human lung cancer cells. Cancer Sci., 2011, 102(5), 1007-1013.
126. Vargas, A.J.; Sittadjody, S.; Thangasamy, T.; Mendoza, E.E.; Limesand, K.H.; Burd R. Exploiting Tyrosinase Expression and Activity in Melanocytic Tumors: Quercetin and the Central Role of p53. Integr. Cancer Ther., 2010, Dec 31. [Epub ahead of print]
127. Nitoda, T.; Isobe, T.; Kubo, I. Effects of phenolic compounds isolated from Rabdosia japonica on B16-F10 melanoma cells. Phytothe. r Res., 2008, 22(7), 867-872.
128. Payton, F.; Bose, R.; Alworth, W.L.; Kumar, A.P.; Ghosh, R. 4-Methylcatechol-induced oxidative stress induces intrinsic apoptotic pathway in metastatic melanoma cells. Biochem. Pharmacol., 2011, 81(10), 1211-1218.
129. Yang, Y.M.; Son, Y.O.; Lee, S.A.; Jeon, Y.M.; Lee,. JC. Quercetin Inhibits alpha-MSH-stimulated Melanogenesis in B16F10 Melanoma Cells. Phytother. Res., 2011, 25(8), 1166-1173
130. Fujii, T.; Saito, M. Inhibitory effect of quercetin isolated from rose hip (Rosa canina L.) against melanogenesis by mouse melanoma cells. Biosci. Biotechnol. Biochem., 2009, 73(9), 1989-1993.
131. Duval, R.E.; Harmand, P.O.; Jayat-Vignoles, C.; Cook-Moreau, J.; Pinon, A.; Delage, C.; Simon, A. Differential involvement of mitochondria during ursolic acid-induced apoptotic process in HaCaT and M4Beu cells. Oncol. Rep., 2008, 19(1), 145-149.
132. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr. 2000, 130, 2073-2085.
133. Manach, C.; Williamson, G.; Morand, C.; Scalbert, A.; Remesy, C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr., 2005, 81(1), 230-242.
134. Seeram, N.P.; Bourquin, L.D.; Nair, M.G. Degradation products of cyanidin glycosides from tart cherries and their bioactivities. J. Agric. Food Chem., 2001, 49(10), 4924-4929.
135. Seeram, N.P.; Adams, L.S.; Zhang, Y.; Lee, R.; Sand, D.; Scheuller, H.S.; Heber, D. Blackberry, black raspberry, blueberry, cranberry, red raspberry, and strawberry extracts inhibit growth and stimulate apoptosis of human cancer cells in vitro. J. Agric. Food Chem., 2006, 54(25), 9329-9339.
136. Duthie, S.J.; Jenkinson, A.M.; Crozier, A.; Mullen, W.; Pirie, L.; Kyle, J.; Yap, L.S.; Christen, P.; Duthie, G.G. The effects of cranberry juice consumption on antioxidant status and biomarkers relating to heart disease and cancer in healthy human volunteers. Eur. J. Nutr., 2006, 45(2), 113-122.
137. Cao, G.; Prior, R.L. Anthocyanins are detected in human plasma after oral administration of an elderberry extract. Clin. Chem., 1999, 45(4), 574-576.
138. Wu, X.; Cao, G.; Prior, R.L. Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J. Nutr., 2002, 132(7), 1865-1871.
139. Wahle, K.W.; Brown, I.; Rotondo, D.; Heys, S.D. Plant phenolics in the prevention and treatment of cancer. Adv. Exp. Med. Biol., 2011, 698, 36-51.
140. Parry, J.; Su, L.; Moore, J.; Cheng, Z.; Luther, M.; Rao, J.N.; et al. Chemical compositions, antioxidant capacities, and antiproliferative activities of selected fruit seed flours. J. Agric. Food Chem., 2006, 54(11), 3773-3778.